These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 30466447
1. Antinuclear antibody and rheumatoid factor positivity in temporomandibular disorders. Kim JR, Jo JH, Chung JW, Park JW. Head Face Med; 2018 Nov 22; 14(1):26. PubMed ID: 30466447 [Abstract] [Full Text] [Related]
5. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course. Hügle B, Hinze C, Lainka E, Fischer N, Haas JP. Pediatr Rheumatol Online J; 2014 Nov 22; 12():28. PubMed ID: 25114627 [Abstract] [Full Text] [Related]
6. Frequency of antinuclear antibodies and rheumatoid factor in healthy Turkish children. Kasapçopur O, Ozbakir F, Arisoy N, Ingöl H, Yazici H, Ozdoğan H. Turk J Pediatr; 1999 Nov 22; 41(1):67-71. PubMed ID: 10770678 [Abstract] [Full Text] [Related]
7. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis]. Us D, Gülmez D, Hasçelik G. Mikrobiyol Bul; 2003 Nov 22; 37(2-3):163-70. PubMed ID: 14593899 [Abstract] [Full Text] [Related]
8. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians. Suarez-Almazor ME, Gonzalez-Lopez L, Gamez-Nava JI, Belseck E, Kendall CJ, Davis P. J Rheumatol; 1998 Oct 22; 25(10):1980-5. PubMed ID: 9779854 [Abstract] [Full Text] [Related]
9. Increased frequency and specific reactivity of serum antinuclear antibodies in patients with nonimmune chronic idiopathic neutropenia of adults. Papadaki HA, Psyllaki M, Eliopoulos DG, Tsiroyianni A, Eliopoulos GD. Acta Haematol; 2001 Oct 22; 105(1):13-20. PubMed ID: 11340248 [Abstract] [Full Text] [Related]
10. Temporomandibular disorders: clinical and laboratory analyses for risk assessment of criteria for surgical therapy, a pilot study. Halpern LR, Chase DC, Gerard DA, Behr MM, Jacobs W. Cranio; 1998 Jan 22; 16(1):35-43. PubMed ID: 9481984 [Abstract] [Full Text] [Related]
11. Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis. Bos WH, Bartelds GM, Wolbink GJ, de Koning MH, van de Stadt RJ, van Schaardenburg D, Dijkmans BA, Nurmohamed MT. J Rheumatol; 2008 Oct 22; 35(10):1972-7. PubMed ID: 18785316 [Abstract] [Full Text] [Related]
12. Antinuclear antibody and rheumatoid factor in silica-exposed workers. Aminian O, Sharifian SA, Mehrdad R, Haghighi KS, Mazaheri M. Arh Hig Rada Toksikol; 2009 Jun 22; 60(2):185-90. PubMed ID: 19581212 [Abstract] [Full Text] [Related]
13. [Nationwide survey for autoantibodies and proposal of a new method for standardization of rheumatoid factors]. Kumagai S, Hayashi N, Ohta T, Akahoshi T, Imafuku Y, Koshiba M. Rinsho Byori; 2009 Jan 22; 57(1):31-41. PubMed ID: 19227188 [Abstract] [Full Text] [Related]
19. ANA+ (anti-nuclear antibody) is correlated with RF+ (rheumatoid factor) in rheumatoid arthritis. Matsos MP, Pope JE, Spencer-Green G. Inflammopharmacology; 2004 Apr 22; 12(3):229-31. PubMed ID: 15527547 [No Abstract] [Full Text] [Related]
20. Young age of onset is associated with increased prevalence of circulating IgM rheumatoid factor and antinuclear antibodies at presentation in women with rheumatoid arthritis. Jacobsen S. Clin Rheumatol; 2004 Apr 22; 23(2):121-2. PubMed ID: 15045625 [Abstract] [Full Text] [Related] Page: [Next] [New Search]